Heron Therapeutics, Inc. · NASDAQ:HRTX
Collard Craig A exercised options for 13,797 Heron Therapeutics, Inc. shares (Form 4)
Traded Oct 19, 2026 · Filed Oct 21, 2026
On Oct 19, 2026, Collard Craig A (Director, Chief Executive Officer) exercised options for 13,797 Heron Therapeutics, Inc. shares, leaving 866,929 shares. Filed Oct 21, 2026 (Form 4).
- Options exercised
- 13,797 shares
- Holding after
- 866,929 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Common Stock | Option exercise | 13,797 | 870,289 | Direct | |
| Oct 19, 2026 | Common Stock | Shares withheld for tax | 3,360 | US$0.36 | 866,929 | Direct |
Source
Download original · View original at SEC
Related
- Heron Therapeutics, Inc.
- Collard Craig A
- Heron Therapeutics, Inc. shareholders
- Form 4 · Collard Craig A · Aug 3, 2026
- Form 4 · Collard Craig A · Jul 20, 2026
- Form 4 · Collard Craig A · May 4, 2026
- Form 4 · Collard Craig A · Apr 21, 2026
- Form 4 · Collard Craig A · Apr 6, 2026
- Form 4 · Duarte Ira · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026
- Form 4 · Forbes William P · Aug 3, 2026